Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney

Norberto Perico, Radoslaw Lapinski, Krzysztof Konopka, Sistiana Aiello, Marina Noris, Giuseppe Remuzzi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Isolated kidney preparations (IPK) from male Sprague Dawley rats perfused at constant pressure were used to evaluate the effect of angiotensin II (AII) and platelet-activating factor (PAF) on renal function and urinary protein excretion. Compared with basal, intrarenal infusion of AII at 8 ng/min caused a progressive increase in protein excretion (11 ± 6 versus 73 ± 21 μg/min) in parallel with a decline in renal perfusate flow (RPF) (29 ± 3 versus 18 ± 3 ml/min). Addition to the perfusate of PAF at 50 nM final concentration also induced proteinuria (9 ± 4 versus 55 ± 14 μg/min) but did not change RPF (29 ± 3 versus 30 ± 3 ml/min). Preexposure of isolated kidneys to the PAF receptor antagonist WEB 2086 prevented the increase in urinary protein excretion induced by AII infusion (basal: 13 ± 6; post-AII: 12 ± 7 μg/min) but failed to prevent the vasoactive effect of AII (RPF, basal: 30 ± 2; post-AII: 21 ± 3 ml/min). In additional experiments, dexamethasone reduced the proteinuric effect of PAF remarkably. These results indicate that in isolated kidney preparation: (1) AII infusion induced proteinuria and decreased RPF; and (2) the effect of AII in enhancing urinary protein excretion was completely prevented by a specific PAF receptor antagonist, which, however, did not influence the AII-induced fall in RPE. It is suggested that PAF plays a major role in AII-induced changes in the permselective function of the glomerular capillary barrier.

Original languageEnglish
Pages (from-to)1391-1398
Number of pages8
JournalJournal of the American Society of Nephrology
Volume8
Issue number9
Publication statusPublished - Sep 1997

Fingerprint

Platelet Activating Factor
Proteinuria
Angiotensin II
Kidney
WEB 2086
Proteins
Dexamethasone
Sprague Dawley Rats
Pressure

ASJC Scopus subject areas

  • Nephrology

Cite this

Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney. / Perico, Norberto; Lapinski, Radoslaw; Konopka, Krzysztof; Aiello, Sistiana; Noris, Marina; Remuzzi, Giuseppe.

In: Journal of the American Society of Nephrology, Vol. 8, No. 9, 09.1997, p. 1391-1398.

Research output: Contribution to journalArticle

@article{32ba132deb2944328b03895bd99e21ce,
title = "Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney",
abstract = "Isolated kidney preparations (IPK) from male Sprague Dawley rats perfused at constant pressure were used to evaluate the effect of angiotensin II (AII) and platelet-activating factor (PAF) on renal function and urinary protein excretion. Compared with basal, intrarenal infusion of AII at 8 ng/min caused a progressive increase in protein excretion (11 ± 6 versus 73 ± 21 μg/min) in parallel with a decline in renal perfusate flow (RPF) (29 ± 3 versus 18 ± 3 ml/min). Addition to the perfusate of PAF at 50 nM final concentration also induced proteinuria (9 ± 4 versus 55 ± 14 μg/min) but did not change RPF (29 ± 3 versus 30 ± 3 ml/min). Preexposure of isolated kidneys to the PAF receptor antagonist WEB 2086 prevented the increase in urinary protein excretion induced by AII infusion (basal: 13 ± 6; post-AII: 12 ± 7 μg/min) but failed to prevent the vasoactive effect of AII (RPF, basal: 30 ± 2; post-AII: 21 ± 3 ml/min). In additional experiments, dexamethasone reduced the proteinuric effect of PAF remarkably. These results indicate that in isolated kidney preparation: (1) AII infusion induced proteinuria and decreased RPF; and (2) the effect of AII in enhancing urinary protein excretion was completely prevented by a specific PAF receptor antagonist, which, however, did not influence the AII-induced fall in RPE. It is suggested that PAF plays a major role in AII-induced changes in the permselective function of the glomerular capillary barrier.",
author = "Norberto Perico and Radoslaw Lapinski and Krzysztof Konopka and Sistiana Aiello and Marina Noris and Giuseppe Remuzzi",
year = "1997",
month = "9",
language = "English",
volume = "8",
pages = "1391--1398",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "9",

}

TY - JOUR

T1 - Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney

AU - Perico, Norberto

AU - Lapinski, Radoslaw

AU - Konopka, Krzysztof

AU - Aiello, Sistiana

AU - Noris, Marina

AU - Remuzzi, Giuseppe

PY - 1997/9

Y1 - 1997/9

N2 - Isolated kidney preparations (IPK) from male Sprague Dawley rats perfused at constant pressure were used to evaluate the effect of angiotensin II (AII) and platelet-activating factor (PAF) on renal function and urinary protein excretion. Compared with basal, intrarenal infusion of AII at 8 ng/min caused a progressive increase in protein excretion (11 ± 6 versus 73 ± 21 μg/min) in parallel with a decline in renal perfusate flow (RPF) (29 ± 3 versus 18 ± 3 ml/min). Addition to the perfusate of PAF at 50 nM final concentration also induced proteinuria (9 ± 4 versus 55 ± 14 μg/min) but did not change RPF (29 ± 3 versus 30 ± 3 ml/min). Preexposure of isolated kidneys to the PAF receptor antagonist WEB 2086 prevented the increase in urinary protein excretion induced by AII infusion (basal: 13 ± 6; post-AII: 12 ± 7 μg/min) but failed to prevent the vasoactive effect of AII (RPF, basal: 30 ± 2; post-AII: 21 ± 3 ml/min). In additional experiments, dexamethasone reduced the proteinuric effect of PAF remarkably. These results indicate that in isolated kidney preparation: (1) AII infusion induced proteinuria and decreased RPF; and (2) the effect of AII in enhancing urinary protein excretion was completely prevented by a specific PAF receptor antagonist, which, however, did not influence the AII-induced fall in RPE. It is suggested that PAF plays a major role in AII-induced changes in the permselective function of the glomerular capillary barrier.

AB - Isolated kidney preparations (IPK) from male Sprague Dawley rats perfused at constant pressure were used to evaluate the effect of angiotensin II (AII) and platelet-activating factor (PAF) on renal function and urinary protein excretion. Compared with basal, intrarenal infusion of AII at 8 ng/min caused a progressive increase in protein excretion (11 ± 6 versus 73 ± 21 μg/min) in parallel with a decline in renal perfusate flow (RPF) (29 ± 3 versus 18 ± 3 ml/min). Addition to the perfusate of PAF at 50 nM final concentration also induced proteinuria (9 ± 4 versus 55 ± 14 μg/min) but did not change RPF (29 ± 3 versus 30 ± 3 ml/min). Preexposure of isolated kidneys to the PAF receptor antagonist WEB 2086 prevented the increase in urinary protein excretion induced by AII infusion (basal: 13 ± 6; post-AII: 12 ± 7 μg/min) but failed to prevent the vasoactive effect of AII (RPF, basal: 30 ± 2; post-AII: 21 ± 3 ml/min). In additional experiments, dexamethasone reduced the proteinuric effect of PAF remarkably. These results indicate that in isolated kidney preparation: (1) AII infusion induced proteinuria and decreased RPF; and (2) the effect of AII in enhancing urinary protein excretion was completely prevented by a specific PAF receptor antagonist, which, however, did not influence the AII-induced fall in RPE. It is suggested that PAF plays a major role in AII-induced changes in the permselective function of the glomerular capillary barrier.

UR - http://www.scopus.com/inward/record.url?scp=0030727234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030727234&partnerID=8YFLogxK

M3 - Article

C2 - 9294830

AN - SCOPUS:0030727234

VL - 8

SP - 1391

EP - 1398

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 9

ER -